Celecoxib does not alter intestinal microbiome in a longitudinal diet-controlled study

Clinical Microbiology and Infection

Volumn 22, Issue 5, 2016, Pages 464-465

  Bokulich, N A ^a   Battaglia, T ^a   Aleman, J O ^b   Walker, J M ^c   Blaser, M J ^a   Holt, P R ^b  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b Laboratory of Biochemical Genetics and Metabolism   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; RNA 16S; CYCLOOXYGENASE 2 INHIBITOR;

ACIDAMINOCOCCACEAE; ADIPOSE TISSUE; CLINICAL ARTICLE; CROSS-SECTIONAL STUDY; DIET; DRUG EFFECT; ENTEROBACTERIACEAE; FECES; FOLLOW UP; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; INFLAMMATION; INTESTINE FLORA; LETTER; LONGITUDINAL STUDY; MICROBIAL DIVERSITY; NONHUMAN; OBESITY; POSTMENOPAUSE; PRIORITY JOURNAL; PYROSEQUENCING; QUESTIONNAIRE; UNITED STATES; ADOLESCENT; ADULT; AGED; CHILD; DRUG EFFECTS; FEMALE; INFANT; MALE; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; PROCEDURES; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CELECOXIB; CHILD; CHILD, PRESCHOOL; CYCLOOXYGENASE 2 INHIBITORS; DIET; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; INFANT; INFANT, NEWBORN; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84962176197     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2016.01.013     Document Type: Letter

References (5)

1. Rogers M.A., Aronoff D.M. The influence of non-steroidal anti-inflammatory drugs on the gut microbiome. Clin Microbiol Infect 2016, 22:178.e1-178.e9.
2. Srisailam K., Veeresham C. Biotransformation of celecoxib using microbial cultures. Appl Biochem Biotechnol 2010, 160:2075-2089.
3. Thangamani S., Younis W., Seleem M.N. Repurposing celecoxib as a topical antimicrobial agent. Front Microbiol 2015, 6:750.
4. Paulson S.K., Hribar J.D., Liu N.W., Hajdu E., Bible R.H., Piergies A., et al. Metabolism and excretion of [14C]Celecoxib in healthy male volunteers. Drug Metab Dispos 2000, 28:308-314.
5. Suissa D., Delaney J.A., Dial S., Brassard P. Non-steroidal anti-inflammatory drugs and the risk of Clostridium difficile-associated disease. Br J Clin Pharmacol 2012, 74:370-375.